Skip to main content

Utilization of Drug-Device or Biologic-Device Combinations: A Descriptive Analysis

    Basic Details
    Date Posted
    Status
    Complete
    Description

    In this request, we examined utilization patterns of ten pediatric drug-device or biologic-device combinations: Admelog (insulin lispro), Humalog KwikPen and Humalog Junior KwikPen (insulin lispro), Beconase (beclomethasone), EpiPen and EpiPen Jr. (epinephrine), epinephrine instramuscular, Evzio (naloxone), fluticasone metered, Neulasta (pegfilgrastim), Humira (adalimumab), and Norditropin (somatropin).

    The study period includes data from January 1, 2018 to March 31, 2019. We executed this request on Merative™ MarketScan® Research Databases on August 27, 2020.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2018 - March 31, 2019
    Analysis Type
    Descriptive
    Population / Cohort
    All individuals
    Data Sources
    Merative™ MarketScan® Research Databases